神经退行性疾病治疗方法开发的最新进展与未来展望
Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases.
作者信息
Bowerman Melissa
机构信息
School of Medicine, Keele University, Staffordshire ST5 5BG, UK.
Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry SY10 7AG, UK.
出版信息
Brain Sci. 2020 Sep 11;10(9):633. doi: 10.3390/brainsci10090633.
Abstract
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD), severely impact the function of neuronal cells in the brain and have devastating consequences on the quality of life of patients and their families [...].
摘要
神经退行性疾病，如阿尔茨海默病（AD）、帕金森病（PD）和亨廷顿病（HD），严重影响大脑中神经元细胞的功能，并对患者及其家人的生活质量产生毁灭性影响[……]。
相似文献
1
Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases.神经退行性疾病治疗方法开发的最新进展与未来展望
Brain Sci. 2020 Sep 11;10(9):633. doi: 10.3390/brainsci10090633.
2
Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).神经疾病的免疫基因网络：多发性硬化症（MS）、阿尔茨海默病（AD）、帕金森病（PD）和亨廷顿病（HD）。
Heliyon. 2021 Dec 1;7(12):e08518. doi: 10.1016/j.heliyon.2021.e08518. eCollection 2021 Dec.
3
The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.免疫系统和神经炎症作为阿尔茨海默病、帕金森病和亨廷顿病血液生物标志物的潜在来源。
ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.
4
Molecular diagnostics of neurodegenerative disorders.神经退行性疾病的分子诊断。
Front Mol Biosci. 2015 Sep 22;2:54. doi: 10.3389/fmolb.2015.00054. eCollection 2015.
5
The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.活性氧在阿尔茨海默病、帕金森病和亨廷顿病发病机制中的作用：一篇综述短文
Oxid Med Cell Longev. 2016;2016:8590578. doi: 10.1155/2016/8590578. Epub 2016 Dec 27.
6
Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology.通过网络生物学剖析神经退行性疾病的分子机制
Front Aging Neurosci. 2017 May 29;9:166. doi: 10.3389/fnagi.2017.00166. eCollection 2017.
7
Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.神经退行性疾病中线粒体动力学异常。
Antioxidants (Basel). 2017 Apr 5;6(2):25. doi: 10.3390/antiox6020025.
8
Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.亨廷顿病猴诱导多能干细胞源性神经祖细胞衍生的星形胶质细胞改善亨廷顿病表型。
PLoS One. 2019 Mar 21;14(3):e0214156. doi: 10.1371/journal.pone.0214156. eCollection 2019.
9
Depression in neurodegenerative diseases: Common mechanisms and current treatment options.神经退行性疾病中的抑郁：共同机制和当前治疗选择。
Neurosci Biobehav Rev. 2019 Jul;102:56-84. doi: 10.1016/j.neubiorev.2019.04.002. Epub 2019 Apr 15.
10
Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases.经颅磁刺激用于理解病理生理学及作为神经退行性疾病的潜在治疗方法。
Transl Neurodegener. 2015 Nov 16;4:22. doi: 10.1186/s40035-015-0045-x. eCollection 2015.
引用本文的文献
1
Understanding the Role of the SMN Complex Component GEMIN5 and Its Functional Relationship with Demethylase KDM6B in the Flunarizine-Mediated Neuroprotection of Motor Neuron Disease Spinal Muscular Atrophy.理解 SMN 复合物成分 GEMIN5 的作用及其与去甲基酶 KDM6B 在氟桂利嗪介导的运动神经元疾病脊髓性肌萎缩神经保护中的功能关系。
Int J Mol Sci. 2024 Sep 18;25(18):10039. doi: 10.3390/ijms251810039.
2
Butanolides and Butenolides from a Marine-Derived sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor.来自一种海洋来源的菌种的丁醇内酯和丁烯醇内酯通过激活TrkB神经营养因子受体发挥神经保护活性。
Mar Drugs. 2023 Aug 25;21(9):465. doi: 10.3390/md21090465.
3
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection.伴侣蛋白依赖的机制作为神经保护的药理学靶点。
Int J Mol Sci. 2023 Jan 3;24(1):823. doi: 10.3390/ijms24010823.
本文引用的文献
1
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
2
The belated US FDA approval of the adenosine A receptor antagonist istradefylline for treatment of Parkinson's disease.美国食品和药物管理局（FDA）姗姗来迟，批准腺苷 A 受体拮抗剂伊曲茶碱用于治疗帕金森病。
Purinergic Signal. 2020 Jun;16(2):167-174. doi: 10.1007/s11302-020-09694-2. Epub 2020 Mar 31.
3
Current and Future Treatments in Alzheimer Disease: An Update.阿尔茨海默病的当前及未来治疗方法：最新进展
J Cent Nerv Syst Dis. 2020 Feb 29;12:1179573520907397. doi: 10.1177/1179573520907397. eCollection 2020.
4
Diagnosis and Treatment of Parkinson Disease: A Review.帕金森病的诊断与治疗：综述。
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
5
A resurrection of aducanumab for Alzheimer's disease.阿杜卡单抗用于治疗阿尔茨海默病的再度兴起。
Lancet Neurol. 2020 Feb;19(2):111-112. doi: 10.1016/S1474-4422(19)30480-6. Epub 2019 Dec 4.
6
Therapeutic Advances for Huntington's Disease.亨廷顿舞蹈症的治疗进展
Brain Sci. 2020 Jan 12;10(1):43. doi: 10.3390/brainsci10010043.
7
Insights into Computational Drug Repurposing for Neurodegenerative Disease.计算药物重用到神经退行性疾病的研究进展。
Trends Pharmacol Sci. 2019 Aug;40(8):565-576. doi: 10.1016/j.tips.2019.06.003. Epub 2019 Jul 17.
8
Targeting Huntingtin Expression in Patients with Huntington's Disease.靶向亨廷顿病患者的亨廷顿蛋白表达。
N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6.
9
Modern approaches to investigating non-neuronal aspects of Alzheimer's disease.现代方法研究阿尔茨海默病的非神经元方面。
FASEB J. 2019 Feb;33(2):1528-1535. doi: 10.1096/fj.201802592.
10
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.神经退行性疾病：再生机制与新型治疗方法
Brain Sci. 2018 Sep 15;8(9):177. doi: 10.3390/brainsci8090177.
Zotero 插件